论文部分内容阅读
为观察早期应用DF－521对脑梗塞近期疗效的影响，设DF－521治疗组及常规治疗组各30例．前者除常规治疗外，在早期应用了DF－521治疗．出院时治愈率分别为53．3％及26．7％，显效治愈率分别为93．3％及60％．两组平均住院天数分别为19．3±7．6及25．1±6．2天．结果提示早期应用DF．521能明显提高脑梗塞的疗效，改善病残程度，还能明显缩短住院天数．因此，早期应用DF－521结合其它常规措施综合治疗，不失为脑梗塞的一种较好治疗万法．
To observe the early application of DF-521 on the short-term efficacy of cerebral infarction, DF-521 treatment group and the conventional treatment group 30 cases. The former in addition to conventional treatment, the early application of DF-521 treatment. The cure rates at discharge were 53.3% and 26.7% respectively, and the effective cure rates were 93.3% and 60% respectively. The mean length of stay in both groups was 19.3 ± 7.6 and 25.1 ± 6.2 days, respectively. The results suggest early application of DF. 521 can significantly improve the efficacy of cerebral infarction, improve the degree of illness, but also significantly reduce the number of hospital days. Therefore, the early application of DF-521 combined with other conventional measures of comprehensive treatment, after all, a better treatment of cerebral infarction method.